Founded in 2010, Life Length stands out as a global leader in diagnostic biotechnology, specializing in telomere diagnostics. Our proprietary platform technology, TAT®, is based on the measurement of telomere variables and assays related to aging and age-related diseases. This patented technique allows quantification of telomere length at the individual cell level and is applicable to blood, cell culture and tissue samples. Recently, we have developed a biomarker for the early detection of prostate cancer with this technology. This biomarker is authorized by the AEMPS in Europe and by the CMS in the United States, and is already available on the European market. We offer a wide range of services based on 𝘪𝘯 𝘷𝘪𝘷𝘰 and 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 essays. Leading clients in more than 30 countries trust us with their custom biomarker projects and solutions. We specialize in the application of our assays in three fundamental fields: diagnosis and prognosis in oncology, personalized and preventive medicine, as well as in the B2B/CRO industry. At Life Length, we are firmly committed to the development and implementation of an effective quality management system that ensures excellence in our services provided. 𝐎𝐮𝐫 𝐚𝐜𝐜𝐫𝐞𝐝𝐢𝐭𝐚𝐭𝐢𝐨𝐧𝐬: • ISO 15189 • CLIA • AEMPS • ISO 13485 • State of California, Rhode Island, Maryland and Pennsylvania licences Our mission at Life Length is to improve health and prolong people's lives by leveraging our cutting-edge technologies and the exceptional talent of our team.